ABIVAX included in the CAC Small, CAC Mid & Small and CAC All-Tradable indices

Paris, September 14th, 2015 – ABIVAX (Euronext Paris: FR0012333284 - ABVX), a leading clinical stage biotech company developing and commercializing anti-viral compounds and human vaccines, today announced that it will be included in the CAC® Small, CAC® Mid & Small and CAC® All-Tradable indices.  This decision was taken by the Scientific Council of Euronext Paris’ indices on September 10th.  ABIVAX’s inclusion in the three indices will take effect on September 18th, 2015 after the close of the Paris stock market.

Press contacts

Caroline Carmagnol 

abivax@alizerp.com

+ 33 6 64 18 99 59 or
+ 33 1 44 54 36 65

 Standard: +33 1 53 83 08 41